Article
Oncology
Connor J. O'Boyle, Giulia Siravegna, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Kim Chang Sing Pang, Jarrod Stein, Julia C. Thierauf, Peter M. Sadow, William C. Faquin, Wei Wang, Daniel G. Deschler, Kevin S. Emerick, Mark A. Varvares, Jong C. Park, John R. Clark, Annie W. Chan, Paul M. Busse, Ryan B. Corcoran, Lori J. Wirth, Derrick T. Lin, A. John Iafrate, Jeremy D. Richmon, Daniel L. Faden
Summary: POD 1 ctHPVDNA levels are associated with the risk of residual disease in patients with HPV+OPSCC undergoing curative intent surgery and could be used as a personalized biomarker for selecting adjuvant treatment in the future.
Article
Virology
Schifra Uwamungu, Bethelehem Nigussie, Claude Mambo Muvunyi, Bengt Hasseus, Maria Andersson, Daniel Giglio
Summary: HPV infections are prevalent in HIV-positive couples in Rwanda, but concordance within couples is low. Vaginal self-sampling can represent cervical HPV status.
Article
Oncology
Shih-Han Hung, Tzong-Hann Yang, Yen-Fu Cheng, Chin-Shyan Chen, Herng-Ching Lin
Summary: This nationwide population-based study aimed to investigate the association between nasopharyngeal carcinoma and human papillomavirus infections. The results indicated a significant difference in the rates of previous human papillomavirus infections between nasopharyngeal carcinoma patients and controls. The adjusted odds ratio showed a significantly higher risk of prior human papillomavirus infections in nasopharyngeal carcinoma cases compared to controls.
Review
Oncology
Biyuan Xing, Jianfeng Guo, Yuhan Sheng, Gang Wu, Yingchao Zhao
Summary: HPV-negative cervical cancers, predominantly adenocarcinomas, pose challenges in diagnosis and management due to unclear etiology and possible false negative results. It is important to pay greater attention to these cases as they are often diagnosed at advanced stages with poor prognoses.
FRONTIERS IN ONCOLOGY
(2021)
Article
Multidisciplinary Sciences
Valeria Denninghoff, Felicitas von Petery, Cristobal Fresno, Mercedes Galarza, Florencia Torres, Alejandra Avagnina, Vanina Fishkel, Hugo Krupitzki, Angel Fiorillo, Fernando Monge
Summary: The HPV test is crucial for preventing cervical cancer, and a screening program using co-testing can help reduce the burden of the disease.
Article
Oncology
Lars Sivars, Kristina Hellman, Ylva Crona Guterstam, Stefan Holzhauser, Magnus Nordenskjold, Henrik Falconer, Kolbrun Palsdottir, Emma Tham
Summary: This study aimed to analyze the detectability of cell-free human papillomavirus DNA (ctHPV DNA) in patients with cervical cancer or pre-malignant lesions and its correlation with patient and tumor characteristics and outcome. The results showed a high proportion of ctHPV DNA detection in patients with locally advanced cervical cancer, and its levels were correlated with disease staging. Furthermore, the presence of ctHPV DNA was associated with worse progression-free survival in patients.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Oncology
Lisa M. Pinatti, Wenjin Gu, Yifan Wang, Ahmed Elhossiny, Apurva D. Bhangale, Collin V. Brummel, Thomas E. Carey, Ryan E. Mills, J. Chad Brenner
Summary: The study presented a new HPV detection pipeline called SearcHPV, based on targeted capture technology, which showed higher sensitivity and specificity in detecting HPV-host integration sites compared to commonly used HPV detection callers. Through integrated analysis, HPV integration sites were found near cancer-related genes and regions of large structural variation, highlighting the importance of accurate detection methods in studying the impact of HPV integration on malignant transformation.
Article
Oncology
Eleni M. Rettig, Daniel L. Faden, Shaiba Sandhu, Kristine Wong, William C. Faquin, Chloe Warinner, Phil Stephens, Sunil Kumar, Charlotte Kuperwasser, Jeremy D. Richmon, Ravindra Uppaluri, Mark Varvares, Rosh Sethi, Glenn J. Hanna, Herve Sroussi
Summary: This study found that circulating tumor HPV DNA can be detected at least several years before the diagnosis of HPV-positive head and neck squamous cell carcinoma (HNSCC) in some patients, which may serve as a biomarker for early diagnosis of HPV16-positive HNSCC.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Article
Immunology
Ramon P. van der Zee, Olivier Richel, Carel J. M. van Noesel, Iuliana Ciocanea-Teodorescu, Annina P. van Splunter, Timo J. Ter Braak, Mayura Nathan, Tamzin Cuming, Michael Sheaff, Alexander Kreuter, Chris J. L. M. Meijer, Wim G. Quint, Henry J. C. de Vries, Jan M. Prins, Renske D. M. Steenbergen
Summary: This study validated the accuracy of 5 methylation markers for the detection and cancer risk stratification of HGAIN. High methylation levels in HGAIN were associated with progression to cancer. These markers provide a promising tool to identify HGAIN in need of treatment.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Yanxia Zhao, Heling Bao, Lan Ma, Bo Song, Jiangli Di, Linhong Wang, Yanqiu Gao, Wenhui Ren, Shi Wang, Hai-Jun Wang, Jiuling Wu
Summary: The study evaluated the effectiveness of HPV testing in the national cervical cancer screening programme in China. Results showed that HPV testing had higher CIN2+ detection rate and PPV compared to cytology, with colposcopy referrals differing by income status in different regions.
Article
Virology
Morvarid Golrokh Mofrad, Zohreh Azita Sadigh, Sanaz Ainechi, Ebrahim Faghihloo
Summary: Viral infections, particularly high-risk HPV, may play a carcinogenic role in breast tumors. The presence of HSV-1 and low-risk HPV in BC samples suggests potential cancer-causing roles for these viruses that warrant further investigation.
Review
Microbiology
Erik Kudela, Eva Kudelova, Erik Kozubik, Tomas Rokos, Terezia Pribulova, Veronika Holubekova, Kamil Biringer
Summary: Estimates suggest that 15 to 20 percent of human malignancies are caused by viruses. Human papillomavirus (HPV) is considered an interesting but controversial risk factor for breast cancer. HPV infection is thought to trigger breast cancer development, followed by cumulative changes over time through interaction with other environmental factors. However, the association between HPV and breast cancer is still inconclusive due to conflicting data and unclear transmission routes. Extensive research with larger studies and unified diagnostic methods is needed to better understand the role of HPV in breast carcinogenesis.
Article
Oncology
Suzana Mittelstadt, Olga Kelemen, Jakob Admard, Axel Gschwind, Andre Koch, Sarah Woerz, Ernst Oberlechner, Tobias Engler, Irina Bonzheim, Annette Staebler, Nicola Weidner, Frank Stubenrauch, Thomas Iftner, Olaf Riess, Christopher Schroeder, Stefan Kommoss, Stephan Ossowski
Summary: This study found that cell-free circulating HPV-DNA in plasma can serve as a biomarker for therapy monitoring in cervical cancer. It is correlated with tumor burden and can be used to detect treatment response and relapse.
BRITISH JOURNAL OF CANCER
(2023)
Review
Biology
Rances Blanco, Diego Carrillo-Beltran, Juan P. Munoz, Alejandro H. Corvalan, Gloria M. Calaf, Francisco Aguayo
Summary: Breast cancer is the most commonly diagnosed malignancy in women globally and HPV is considered a potential risk factor for its development. However, further epidemiological and experimental evidence is required to determine the role of HR-HPV infection in the progression of BC.
Article
Multidisciplinary Sciences
Mpho Keetile, Kagiso Ndlovu, Gobopamang Letamo, Mpho Disang, Sanni Yaya, Kannan Navaneetham
Summary: This study assessed factors associated with breast and cervical cancer screening in Botswana, revealing lower likelihood of screening among women in poorer wealth quintiles. Wealth status was found to be the leading contributor to socioeconomic inequality in screening, highlighting the need for concerted efforts to address healthcare needs of the poor.
Article
Virology
Hicham El Hadi, Abdelouaheb Benani, Zineb Qmichou, Fatiha Lazar, Youssef Bakri, Hassan Ait Benhassou, Abdeladim Moumen
JOURNAL OF MEDICAL VIROLOGY
(2019)
Article
Agricultural Engineering
Abdelhakim Bouyahya, Omar Belmehdi, Abdelaziz Benjouad, Rabii Ameziane El Hassani, Saaid Amzazi, Nadia Dakka, Youssef Bakri
INDUSTRIAL CROPS AND PRODUCTS
(2020)
Article
Genetics & Heredity
Aissam El Aliani, Hassan El Abid, Yassmine Kassal, Meriem Khyatti, Mohammed Attaleb, Moulay Mustapha Ennaji, Mohamed El Mzibri
Review
Oncology
Aissam El Aliani, Hassan El-Abid, Yassine El Mallali, Mohammed Attaleb, Moulay Mustapha Ennaji, Mohammed El Mzibri
Summary: DNA methylation is a key epigenetic event related to gene silencing and carcinogenesis. The meta-analysis evaluated the association between promoter methylation of specific genes and the risk of cervical cancer development, finding higher methylation frequencies in certain genes in cervical cancer cases compared to controls. Promoter methylation could potentially serve as a promising noninvasive biomarker for early cervical lesions.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
(2021)
Article
Genetics & Heredity
Khaoula Hadami, Charles Saby, Nadia Dakka, Guillaume Collin, Mohammed Attaleb, Meriem Khyatti, Abdelkarim Filali-Maltouf, Hamid Morjani, Mohammed El Mzibri
Summary: Cervical cancer is the second most diagnosed cancer in Moroccan women, with persistent infection with HPV16 being the main etiological factor. The study found significant differences in p53 degradation activity among HPV16-E6 variants, with African variants showing the most significant impact in this aspect.
Article
Oncology
Meryem El Azzouzi, Hajar El Ahanidi, Chaimae Hafidi Alaoui, Imane Chaoui, Laila Benbacer, Mohamed Tetou, Ilias Hassan, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Mohammed Attaleb
Summary: This study evaluated the methylation status of hTERT, TWIST1, VIM, and NID2 genes in bladder cancer and found frequent hypermethylation of these genes. There was no significant association between promoter methylation of these genes and tumor stage/grade. However, TWIST1 hypermethylation was associated with tumor recurrence. These findings suggest that methylation may play a critical role in bladder cancer development and progression.
Article
Oncology
Hajar El Ahanidi, Meryem El Azzouzi, Chaimae Hafidi Alaoui, Mohammed Tetou, Mounia Bensaid, Imane Chaoui, Laila Benbacer, Ilias Hassan, Mohamed Oukabli, Katarzyna Michaud, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Camilla Jandus, Mohammed Attaleb
Summary: The loop involving TERT, PD-1 ligands, and miR-138-5p in bladder cancer may serve as a promising therapeutic target and also a useful biomarker for improved diagnosis and patients' stratification.
FRONTIERS IN ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Hanaa Skhoun, Mohammed Khattab, Aziza Belkhayat, Zahra Takki Chebihi, Youssef Bakri, Nadia Dakka, Jamila El Baghdadi
Summary: The study finds a significant association between TP53 gene polymorphisms and genetic susceptibility to childhood acute lymphoblastic leukemia (ALL) in Morocco.
MOLECULAR BIOLOGY REPORTS
(2022)
Article
Urology & Nephrology
Meryem El Azzouzi, Hajar El Ahanidi, Chaimae Hafidi Alaoui, Imane Chaoui, Laila Benbacer, Mohamed Tetou, Ilias Hassan, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Mohammed Attaleb
Summary: In this study, the promoter methylation status of bladder cancer was assessed using tumor biopsies and urine sediments. The results showed that urine samples have high specificity and sensitivity for detecting promoter hypermethylation, making it a useful non-invasive approach for assessing methylation status.
AFRICAN JOURNAL OF UROLOGY
(2022)
Article
Chemistry, Multidisciplinary
Kaoutar Bouothmany, Mohammed Bourhia, Noura Aoussar, Mohammed Attaleb, Ahmad M. Salamatullah, Hiba-Allah Nafidi, Fouad Mellouki, Mohammed El Mzibri, Mourad A. M. Aboul-Soud, Laila Benbacer
Summary: This study investigated the chemical composition, antioxidant, and antiproliferative properties of C. ladanifer crude extracts. The results showed that the ethanolic extract exhibited significant antioxidant activity and the extracts exhibited significant antiproliferative activity against cancer cells. The extracts also exhibited minimal toxicity against human skin-derived fibroblast cells.
APPLIED SCIENCES-BASEL
(2022)
Article
Oncology
Chaimae Hafidi Alaoui, Mohammed Tetou, Ilias Hassan, Meryem El Azzouzi, Hajar El Ahanidi, Abdelkarim Filali-Maltouf, Imane Chaoui, Mounia Bensaid, Laila Benbacer, Mohamed Oukabli, Abderrahmane Al Bouzidi, Mohammed Attaleb, Mohammed El Mzibri, Ahmed Ameur
Summary: This preliminary study evaluated the validity of the EORTC and CUETO risk tables in predicting recurrence and progression in Moroccan NMIBC patients. The results showed that the CUETO scoring model was better for recurrence stratification, while both tables overestimated the risk in 1-year and underestimated the risk in 5-years. Prior recurrence rate had a significant effect on both recurrence-free survival and progression-free survival.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
(2022)
Article
Oncology
Rajaa Benzeid, Amina Gihbid, Nadia Benchekroun, Karima Bendahhou, Naima El Benna, Amal Guensi, Abdellatif Benider, Nezha Tawfiq, Abdelkarim Filali Maltouf, Mohammed El Mzibri, Mohammed Attaleb, Meriem Khyatti, Mane Chaoui
Summary: The study aimed to evaluate the association between GSTP1 Ile105Val and GPX1 Pro198Leu polymorphisms and response to radiotherapy in NPC patients, but no significant association was found between genetic polymorphisms and socio-demographic, clinico-pathological features, or response to radiotherapy.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Hajar El Ahanidi, Meryem El Azzouzi, Housna Arrouchi, Chaimae Hafidi Alaoui, Mohammed Tetou, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Mohammed Attaleb
Summary: This study evaluated the mutational status of PIK3CA and AKT1 genes in bladder cancer patients and assessed the association between these mutations and patients' clinicopathological features. The results showed that mutations in AKT1 and PIK3CA are rare events and have no significant association with patients' clinicopathological parameters. The detection of these mutations in voided urine samples showed high specificity and moderate sensitivity.
PAN AFRICAN MEDICAL JOURNAL
(2022)
Article
Biotechnology & Applied Microbiology
Abdelhakim Bouyahya, Fatima Lagrouh, Nasreddine El Omari, Ilhame Bourais, Meryem El Jemli, Ilias Marmouzi, Najoua Salhi, My El Abbes Faouzi, Omar Belmehdi, Nadia Dakka, Youssef Bakri
BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY
(2020)
Article
Public, Environmental & Occupational Health
Abdelhaldm Bouyahya, Omar Belmehdi, Jamal Abrini, Nadia Dakka, Youssef Bakri
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
(2019)